Literature DB >> 21774718

Efficacy and safety of sirolimus in lymphangioleiomyomatosis.

Yujiro Kida.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21774718     DOI： 10.1056/NEJMc1106358

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  2 in total

1.  Lung-selective mRNA delivery of synthetic lipid nanoparticles for the treatment of pulmonary lymphangioleiomyomatosis.

Authors:  Min Qiu; Yan Tang; Jinjin Chen; Rachel Muriph; Zhongfeng Ye; Changfeng Huang; Jason Evans; Elizabeth P Henske; Qiaobing Xu
Journal:  Proc Natl Acad Sci U S A       Date:  2022-02-22       Impact factor: 12.779

2.  Combined treatment of mitoxantrone sensitizes breast cancer cells to rapalogs through blocking eEF-2K-mediated activation of Akt and autophagy.

Authors:  Yidi Guan; Shilong Jiang; Wenling Ye; Xingcong Ren; Xinluan Wang; Yi Zhang; Mingzhu Yin; Kuansong Wang; Yongguang Tao; JinMing Yang; Dongsheng Cao; Yan Cheng
Journal:  Cell Death Dis       Date:  2020-11-03       Impact factor: 8.469
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.